Arclin Inc. Overview
Arclin is a sponsor-owned materials science group that has rebuilt itself from a regional supplier of wood-panel resins and paper overlays into a diversified protective-materials platform. Until 2021 it was a North American formaldehyde-resin and surface-overlay producer tied to housing. Under TJC it added methylamines and DMF, dispersants, polymer additives, engineered repair systems, UK protective films and a fire-resistant sheathing brand (Firepoint). On 1 April 2026 it closed the roughly USD 1.8 billion purchase of DuPont's Aramids business, taking ownership of Kevlar and Nomex, a unit with USD 1.3 billion of 2024 sales that is larger than legacy Arclin appears to have been. The company now sells into construction, defence, aerospace, electrical infrastructure, electric vehicles, agriculture and pharmaceuticals from more than 30 sites on four continents. Its defining features are brand strength in aramids, high acquisition-driven leverage, minimal financial disclosure and an integration workload that management itself calls the near-term priority.
Employee trend from public statements (USD not applicable; headcount):
FY2021 is "more than 600 employees in 12 facilities" (PE Professional, Aug 2021). FY2025 is the "existing 1,200-person team" cited in December 2025 after the Polymer Solutions Group deal added about 200 to a 1,000-person base.
Company's own description. There is no annual report. In its 2026 press-release boilerplate Arclin describes itself as a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for construction, agriculture, transportation infrastructure, weather and fire protection, pharmaceutical, nutrition, electronics, design and other industries, headquartered in Alpharetta with facilities across North and South America, Europe and Asia.
Independent characterization. Arclin is best understood as three businesses under one sponsor-built roof:
-
Legacy engineered building solutions and wood-panel resins. Urea, melamine and phenolic polymers sold to engineered-wood producers, plus resin-saturated paper overlays for concrete forming, paint-grade siding, decorative surfaces and protective panels. Moody's noted in 2021 that resin can only be shipped economically over a limited distance, so Arclin is often the sole supplier to a customer's nearest mill and holds long-term contracts with raw-material pass-through. CEO Bradley Bolduc told Chemical Week in May 2026 that what appears to be this historical core fell from about 80% of revenue a decade ago to under 30% today (the article extract does not name the business explicitly).
-
Acquired specialty chemistries. Methylamines and DMF (Belle, WV), dispersants (Cedartown, GA and Candiac, Québec), elastomer and rubber additives (Cleveland, OH and Albany, GA), and the Willamette Valley Company portfolio of wood-products patching, railroad, concrete-repair and consumer products.
-
Aramids. Kevlar para-aramid, Nomex meta-aramid fibre and paper, Kevlar EXO and Tensylon, sold globally into personal protection, defence, aerospace, electrical insulation, EVs and industrial uses.
Revenue model. Product sales (business-to-business). No subscription or licensing revenue is disclosed; brand licensing of Kevlar and Nomex to downstream garment makers exists commercially but its revenue is not disclosed. Mix by product type is not publicly disclosed.
Value-chain position. Upstream to midstream: Arclin converts commodity feedstocks (methanol, urea, phenol, melamine, ammonia, aramid monomers) into resins, intermediates, fibres, papers and treated panels sold to manufacturers, weavers, converters and distributors. Firepoint moves it one step downstream into branded building products sold through lumber distribution.
Customers and end-markets. Engineered-wood and panel producers, builders and distributors, PPE and ballistic-armour makers, transformer and motor OEMs, aerospace composite fabricators, tyre and rubber compounders, agricultural formulators, pharmaceutical and electronics chemical users. The website lists 12 industries: agriculture; building and construction; defence; electronics; energy and mining; fire and safety; housing; industrial; mobility, automotive and marine; pharmaceuticals and nutrition; textiles; water treatment.
Strategy
There is no annual report or investor day. Strategy is drawn from executive interviews and releases in 2025–2026.
Diversification away from housing-linked resins: Bolduc says the focus has been to diversify by end market and geography, with the historical core now under 30% of revenue (Chemical Week, May 2026).
Protection-focused identity: The PSG release describes a continuing transformation into a protection-focused materials company; Firepoint and the aramid brands anchor that message.
Aramids as an innovation platform: Management says the value of Kevlar and Nomex lies in application know-how, not the molecule, and plans next-generation Kevlar products and Nomex nano products (Chemical Week).
Higher R&D intensity: Target of about 2.5–3% of revenue, up from 1–1.5% historically.
Integration first: Bolduc says absorbing Kevlar, Nomex and the other acquisitions is the priority for now.
Capacity investment: Dillon, SC (USD 60 M+), Belle methylamines and DMF, Firepoint production assets, and stated investment in aramid manufacturing.
Sustainability positioning: ISCC PLUS certification at Spruance (April 2026) and UN Global Compact membership (August 2026).
Medium-term financial targets, cost-programme targets and guidance: not publicly disclosed.
Products & Services
Pricing is not disclosed for any line. Launch years are given only where verified.
Aramids
Engineered Building Solutions
Performance Polymers
Product Portfolio
| Product / brand | Description | Target customers and uses | Notes |
|---|---|---|---|
Kevlar | Para-aramid fibre, high strength-to-weight | Ballistic armour, cut-resistant PPE, aerospace composites, tyres, ropes, industrial reinforcement | Acquired 1 Apr 2026; DuPont described the unit as inventor and largest global producer of these fibres |
Kevlar EXO | Next-generation aramid fibre for lighter ballistic protection | Soft armour, EOD suits | Used in BSST's new EOD suit (June 2026) |
Nomex | Meta-aramid fibre and paper, heat and flame resistant | Firefighter turnout gear, industrial FR apparel, transformer, motor and EV electrical insulation, aerospace honeycomb | Nomex Xtreme Arc fabric and ArmorCell technology showcased Sept 2026 |
Tensylon | Listed on the Arclin brand page with the aramids portfolio | Armour applications | — |
| Product / brand | Description | Target customers |
|---|---|---|
Firepoint | Fire-resistant structural sheathing, including a 10-foot OSB panel introduced at IBS 2026 | Builders in wildfire-prone (WUI) regions; stocked by Capital Lumber in California from Sept 2026 |
Concrete forming overlays | Resin-saturated overlays for plywood form panels | Panel and plywood mills, formwork suppliers |
Paint grade overlays | Paintable overlay surfaces for siding and trim | Siding and panel producers |
Decorative overlays | Decorative surface papers for furniture and interiors | Laminators, furniture and flooring producers |
Protective overlays | Weather and abrasion barriers for panels | Building products manufacturers |
Specialty engineered overlays | Custom overlays for industrial and transport panels | Industrial OEMs |
International overlays | Overlay range for non-North American markets | Export customers |
Panel products and panel solutions | Finished and treated panels; the Dillon, SC site makes components for vapor barriers, floor underlayment, concrete forms, siding and sheathing | Building products channel |
Finishing services | Panel coating and finishing | Panel producers |
Trade Fabrication Systems | UK protective films and panel finishing (Warrington) | UK and European construction and transport |
Arctek, EPIC, Captive | — | — |
| Product / brand | Description | Target customers |
|---|---|---|
Urea, melamine and phenolic polymers | Bonding resins for engineered wood, nonwovens and paper impregnation | Wood-panel and engineered-wood mills |
Methylamines and derivatives; DMF | Amines and solvent produced at Belle, WV (expansion announced Aug 2024) | Water treatment, pharma, agriculture, oil and gas, electronics |
Solvents; intermediates and additives | Derivative chemistries including peptide-coupling materials cited on the website | Pharma and nutrition, electronics |
Dispersants, plasticizers and wetting agents | From RG Dispersants and related sites (Cedartown, GA; Candiac, Québec) | Construction, agriculture, industrial |
Elastomers and polymer additives | PSG polymer additives, dispersions and release agents | Rubber, plastics, engineered wood |
NitroGain | Agricultural nitrogen product brand; the website references fertilizers | Agriculture |
WVCO lines | Wood-products patch and repair, railroad, concrete repair, infrastructure, consumer products; wax and sealants; paints and coatings; robotics integration (Eugene, OR) | Wood products mills, railroads, contractors |
Milling | Sites at Centralia, WA; Lodi, CA; Malad City, ID (products not specified) | — |
“—” = not publicly disclosed.
Financial Narrative
Arclin publishes no financial statements and declined to give revenue figures to Chemical Week in May 2026. The standard five-year tables are shown with blank cells (not publicly disclosed), followed by every disclosed data point located.
Income statement (USD M)
EPS (basic and diluted) and dividends per share are not applicable to an unlisted company. Margins and revenue CAGR cannot be computed.
Balance sheet, cash flow and ratios. Total assets, cash, total debt (short/long split), net debt, equity, goodwill and intangibles, working capital, operating cash flow, capex, free cash flow, buybacks, ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: all not publicly disclosed for FY2021–FY2025.
Disclosed data points
Commentary. Three things can be said with confidence. First, legacy Arclin was a roughly USD 0.55–0.65 billion revenue business for most of 2006–2020, with Moody's-adjusted EBITDA margins around 21% in the first nine months of 2020 (USD 90 M on USD 421 M). Second, management claims more than 15 consecutive years of organic EBITDA growth (Bolduc, Textile World, May 2026); this is unaudited and cannot be tested. Third, the Aramids deal more than doubles the company: Aramids alone had USD 1.33 billion of sales and about USD 262 million of Operating EBITDA in 2024, and H1 2025 run-rate was slightly higher on sales with a similar margin. The price implies about 6.9x FY2024 Operating EBITDA and about 1.35x sales (derived), a modest multiple for a branded specialty asset that reflects cyclicality, Asian competition and carve-out complexity. The H1 2025 net loss at Aramids is a DuPont discontinued-operations figure; its composition was not examined here.
Leverage is the central financial issue. The reported debt package of roughly USD 3.25 billion drawn (loans plus bonds), plus the USD 300 million DuPont note, sits against Aramids EBITDA of about USD 262 million plus an undisclosed legacy and bolt-on contribution. Total leverage cannot be computed without legacy EBITDA, and no figure is offered here.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Operating Grouping Details
| Operating grouping | Contents | Evidence |
|---|---|---|
Engineered Building Solutions (EBS) | Concrete-forming, paint-grade, decorative, protective, international and specialty overlays; panel products and panel solutions; finishing services; Firepoint; Trade Fabrication Systems | Website product menu; Pogue was President of EBS 2021–2025 |
Performance Polymers (formerly Performance Products) | Urea, melamine and phenolic polymers; amines, solvents, intermediates and additives; dispersants, plasticizers and wetting agents; elastomers; WVCO wax, sealants, paints and coatings | Website product menu; Yobp was President of Performance Products |
Aramids (business unit, listed on website under Performance Polymers) | Kevlar, Kevlar EXO, Nomex, Tensylon | Matt Reinhardt is Business Unit President, Aramids |
Segment Overview
| Segment | FY2024 |
|---|---|
Aramids net sales under DuPont ownership (USD Mn) | 1,332 |
Aramids Operating EBITDA under DuPont ownership (USD Mn) | 262 |
Aramids Operating EBITDA margin (%) | 19.7 |
Data Point Details
| Data point | Value | Period | Source |
|---|---|---|---|
Dynea North America annual sales | above USD 550 M | 2006 | Investment Executive |
Arclin annual sales at renaming | above USD 650 M | 2007 | Benefits Canada |
Debt before and after restructuring | USD 234 M to USD 60 M | 2009 | Global Insolvency |
Revenue, last twelve months | USD 562 M | LTM Sept 2020 | Moody's |
Sales, nine months | USD 421 M (down 8% YoY) | 9M 2020 | Moody's |
Moody's-adjusted EBITDA, nine months | USD 90 M | 9M 2020 | Moody's |
Moody's pro forma debt/EBITDA | 5.8x (from 5.2x) | FY2020 pro forma | Moody's |
Dividends to Lone Star | nearly USD 200 M cumulative, including USD 115 M in Feb 2021 | 2018–2021 | Moody's |
ABL revolver | USD 75 M | 2021 | Moody's |
Aramids net sales | USD 1,332 M | FY2024 | DuPont 8-K Ex. 99.1 |
Aramids net income / Adjusted Earnings / Operating EBITDA | about USD 98 M / USD 193 M / about USD 262 M | FY2024 | DuPont 8-K Ex. 99.1 |
Aramids net sales / Operating EBITDA | USD 675 M / about USD 129 M | H1 2025 | DuPont 8-K Ex. 99.1 |
Aramids net loss (discontinued-operations basis) | about USD 734 M | H1 2025 | DuPont 8-K Ex. 99.1 |
Aramids purchase consideration | about USD 1.2 B cash + USD 300 M note + equity valued USD 325 M | Signed Aug 2025 | DuPont release |
Reported acquisition financing | about USD 2.25 B term loans (USD and EUR), about USD 1 B privately placed high-yield bonds, USD 500 M revolver | Early 2026 | Bloomberg via The Middle Market |
R&D intensity | historically 1–1.5% of revenue; target 2.5–3% | 2026 | Chemical Week |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable (unlisted) |
EV/EBITDA, EV/Sales | Not computable for the group. Transaction marker: Aramids acquired at about 6.9x FY2024 Operating EBITDA and about 1.35x FY2024 sales (derived from DuPont figures) |
Analyst consensus | None (no equity coverage) |
Dividend policy | Not disclosed; prior owner took nearly USD 200 M in dividends 2018–2021 |
Credit ratings | Moody's B2 CFR, stable (February 2021, under Lone Star). |
Capital Instruments
| Instrument | Amount | Pricing / maturity | Source |
|---|---|---|---|
2021 first-lien term loan (New Arclin U.S. Holding Corp.) | — | SOFR + 3.50%; due 22 Sep 2028 | Fund N-PORT filings, 2026 |
Acquisition term loans, USD and EUR tranches | About USD 2.25 B | — | Bloomberg via The Middle Market |
Privately placed high-yield bonds | About USD 1 B | — | Bloomberg via The Middle Market |
Revolving credit facility | USD 500 M | — | Bloomberg via The Middle Market |
DuPont note | USD 300 M | Terms not disclosed | DuPont release |
“—” = not publicly disclosed.
Analyst Conclusions
Guidance and consensus. None published. Management's stated direction is integration, higher R&D and continued investment in aramid manufacturing.
Bull case
-
Arclin bought a USD 1.3 billion, roughly 20%-margin branded franchise at under 7x EBITDA, with the seller rolling equity.
-
Structural demand from grid build-out, EV insulation, defence and wildfire-resistant construction lines up with the new portfolio.
-
A management team with long tenure and a claimed 15-year organic EBITDA growth record now has scale and an R&D budget to match.
Bear case
-
Leverage is high and partly floating, with a legacy term loan due in 2028 and a business exposed to housing and industrial cycles.
-
Integration risk is concentrated: a DuPont carve-out, WVCO and PSG all at once, with new COO, CHRO and CIO hires still bedding in.
-
Aramid pricing faces sustained pressure from Asian producers, and Arclin's historical R&D intensity was low for a technology-led fibre business.
Catalysts and monitorables (next 12 months)
-
First rating-agency publications on the post-acquisition capital structure.
-
Any refinancing of the September 2028 term loan.
-
Dillon expansion start-up and Firepoint volume ramp in California.
-
Whether the FMS partnership moves from exploration to contract.
-
Aramid capacity or restructuring announcements at Spruance, Maydown and Asturias.
-
DuPont's quarterly commentary on the carrying value of its Arclin stake and note, the only recurring public window into Arclin's performance.
-
Further bolt-on M&A versus a pause for integration.
Analyst verdict. Arclin is no longer the company its credit history describes. In five years under TJC it has gone from a USD 0.5–0.6 billion North American resin and overlay producer to a global materials group whose largest business is the world's best-known aramid franchise. The strategic logic holds together: the legacy resin operation is a cash-generative regional near-monopoly, the bolt-ons add adjacent chemistries, and Kevlar and Nomex bring brand, technology and access to defence, aerospace and electrical markets with stronger secular demand than housing.
The difficulty is that almost everything needed to judge whether the logic is working is hidden. There are no financial statements, no segment data, no current public rating commentary located, and management declined to give revenue as recently as May 2026. What is visible points to a balance sheet carrying well over USD 3 billion of acquisition-related debt against earnings that, for the largest unit, softened slightly in early 2025. The purchase multiple was low for a reason: aramids are cyclical, capital-intensive and exposed to capable Asian competitors, and DuPont chose to sell.
Execution over the next twelve to eighteen months will decide the outcome. Arclin must separate five plants and about 1,800 people from DuPont, absorb WVCO and PSG, bring new capacity online and lift R&D, all while servicing the debt. The management bench has been strengthened with outside operators, and DuPont's retained equity is a useful signal of confidence, but the margin for error is thin.
For counterparties, the practical conclusion is this: Arclin is a strategically stronger and operationally riskier company than it was a year ago. Customers and suppliers should treat it as a credible long-term owner of Kevlar and Nomex while monitoring leverage. Anyone needing financial assurance should request information directly, because the public record cannot supply it.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Joined / tenure | Background and education |
|---|---|---|---|
Bradley Bolduc | Chief Executive Officer | Joined 2012; President and CEO from early 2021 | Earlier roles across Specialty Chemicals, Decorative Surfaces and Resins; previously AlzChem AG; BSc, University of Maine |
Mark Glaspey | President | Joined 2002; COO 2023; President 2025 | Technical sales, manufacturing and operations leadership; MSc and BSc, Penn State |
Jeff Johnson | Chief Financial Officer | Joined early 2022 | Former CFO of Sigura Water, Tensar and Royal Oak; chief accounting officer at Tempur-Pedic and Scientific Games; Arthur Andersen; University of Kentucky; MBA, University of Chicago |
Jeff Fleck | Chief Operating Officer | Recent hire (date not disclosed) | Former Chief Global Operations Officer, Quaker Houghton; Georgia-Pacific; Zep; BSc Chemical Engineering, Illinois; MBA, Iowa State |
Ralf D. Yobp | Chief Commercial Officer | Joined 1994; CCO 2025 | Former COO and President of Performance Products; MSc and BSc Wood Engineering, Penn State |
Matt Pogue | Chief Strategy Officer | Joined 2012; CSO 2025 | President of EBS from 2021; MBA, Kennesaw State |
Teong Tan | Chief Research Officer | Joined 2001 | Leads technical strategy, IP and growth and innovation; MBA, University of Toronto; MSc, University of Oregon |
Chris Adams | Chief Legal Officer and Corporate Secretary | Joined 2021; outside counsel since 2012 | BA Colgate; JD, University of Maine |
Mark Jordan | Chief Human Resources Officer | Recent hire (date not disclosed) | Former global HR leader at DuPont; Brink's; MBA, University of Ulster |
Ashish Jawadiwar | Global Chief Information Officer | Recent hire (date not disclosed) | Public-company IT and M&A integration experience |
Greg McNulty | Chief Information Officer | Joined 2012 | Led ERP consolidation and acquisition integration; BSc, University of Georgia |
Jana Wright | Chief Marketing and Communications Officer | Joined 2024; promoted 2025 | BA Journalism, University of Georgia |
Matt Reinhardt | Business Unit President, Aramids | Joined with Aramids, April 2026 | Named in closing release |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
Affiliate of TJC, L.P. | Controlling; exact percentage not disclosed | Arclin releases |
DuPont de Nemours, Inc. | About 17.5% non-controlling common equity (valued USD 325 M at signing) plus USD 300 M note receivable | DuPont release, 29 Aug 2025 |
Management | Equity stake retained since 2021; size not disclosed | PE Professional 2021 |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Relative positioning |
|---|---|---|
Para-aramid fibre | Teijin Aramid (Twaron, Technora); Kolon Industries (Heracron); Hyosung Advanced Materials; Yantai Tayho Advanced Materials | Kevlar is the founding brand; DuPont called the unit the largest global producer |
Meta-aramid fibre and paper | Teijin (Teijinconex); Yantai Tayho; Huvis; Toray | Nomex leads in electrical insulation paper and FR apparel |
UHMWPE and alternative ballistic materials | Avient (Dyneema); Honeywell (Spectra) | Substitutes in armour |
Wood-panel resins | Hexion; Bakelite Synthetics (including the former Georgia-Pacific Chemicals) | Regional, logistics-bound; Arclin often sole local supplier per Moody's |
Methylamines and DMF | Eastman; Balchem; BASF | Arclin operates one North American site |
Fire-rated sheathing | LP Building Solutions (FlameBlock); Hoover Treated Wood Products | Firepoint is a 2025 entrant |
Competitor Detail
| Metric | Arclin |
|---|---|
Revenue | Not publicly disclosed (Aramids unit alone: USD 1,332 M, FY2024) |
EBITDA margin | Aramids unit about 19.7% (FY2024) |
R&D intensity | 1–1.5% historical; 2.5–3% target |
Recent Developments
New executive hires (COO, CHRO, Global CIO) appear on the website with profile assets dated May 2026; appointment dates were not announced.



